167 related articles for article (PubMed ID: 11839763)
1. Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of ApoB in lipid transport and metabolism of the apoB-containing lipoprotein.
Chen Z; Fitzgerald RL; Schonfeld G
J Biol Chem; 2002 Apr; 277(16):14135-45. PubMed ID: 11839763
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB.
Srivastava RA; Toth L; Srivastava N; Hinsdale ME; Maeda N; Cefalu AB; Averna M; Schonfeld G
Mol Cell Biochem; 1999 Dec; 202(1-2):37-46. PubMed ID: 10705993
[TBL] [Abstract][Full Text] [Related]
3. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
Chen Z; Fitzgerald RL; Averna MR; Schonfeld G
J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242
[TBL] [Abstract][Full Text] [Related]
4. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies.
Krul ES; Parhofer KG; Barrett PH; Wagner RD; Schonfeld G
J Lipid Res; 1992 Jul; 33(7):1037-50. PubMed ID: 1431583
[TBL] [Abstract][Full Text] [Related]
5. ApoB-54.8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the apoB gene and hypobetalipoproteinemia.
Wagner RD; Krul ES; Tang J; Parhofer KG; Garlock K; Talmud P; Schonfeld G
J Lipid Res; 1991 Jun; 32(6):1001-11. PubMed ID: 1940616
[TBL] [Abstract][Full Text] [Related]
6. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
Lin X; Chen Z; Yue P; Averna MR; Ostlund RE; Watson MA; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1170-6. PubMed ID: 16455790
[TBL] [Abstract][Full Text] [Related]
7. A truncated species of apolipoprotein B, B-83, associated with hypobetalipoproteinemia.
Farese RV; Garg A; Pierotti VR; Vega GL; Young SG
J Lipid Res; 1992 Apr; 33(4):569-77. PubMed ID: 1527480
[TBL] [Abstract][Full Text] [Related]
8. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
Dashti N
J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
[TBL] [Abstract][Full Text] [Related]
9. Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins.
McLeod RS; Zhao Y; Selby SL; Westerlund J; Yao Z
J Biol Chem; 1994 Jan; 269(4):2852-62. PubMed ID: 8300620
[TBL] [Abstract][Full Text] [Related]
10. A gene-targeted mouse model for familial hypobetalipoproteinemia. Low levels of apolipoprotein B mRNA in association with a nonsense mutation in exon 26 of the apolipoprotein B gene.
Kim E; Ambroziak P; Véniant MM; Hamilton RL; Young SG
J Biol Chem; 1998 Dec; 273(51):33977-84. PubMed ID: 9852051
[TBL] [Abstract][Full Text] [Related]
11. Expression of apolipoprotein B in the kidney attenuates renal lipid accumulation.
Krzystanek M; Pedersen TX; Bartels ED; Kjaehr J; Straarup EM; Nielsen LB
J Biol Chem; 2010 Apr; 285(14):10583-90. PubMed ID: 20103594
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice expressing full-length human apolipoprotein B-100. Full-length human apolipoprotein B mRNA is essentially not edited in mouse intestine or liver.
Xiong W; Zsigmond E; Gotto AM; Reneker LW; Chan L
J Biol Chem; 1992 Oct; 267(30):21412-20. PubMed ID: 1400454
[TBL] [Abstract][Full Text] [Related]
13. Four new mutations in the apolipoprotein B gene causing hypobetalipoproteinemia, including two different frameshift mutations that yield truncated apolipoprotein B proteins of identical length.
Young SG; Pullinger CR; Zysow BR; Hofmann-Radvani H; Linton MF; Farese RV; Terdiman JF; Snyder SM; Grundy SM; Vega GL
J Lipid Res; 1993 Mar; 34(3):501-7. PubMed ID: 8468533
[TBL] [Abstract][Full Text] [Related]
14. Amino terminal 38.9% of apolipoprotein B-100 is sufficient to support cholesterol-rich lipoprotein production and atherosclerosis.
Chen Z; Fitzgerald RL; Saffitz JE; Semenkovich CF; Schonfeld G
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):668-74. PubMed ID: 12615667
[TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
16. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia.
Burnett JR; Shan J; Miskie BA; Whitfield AJ; Yuan J; Tran K; McKnight CJ; Hegele RA; Yao Z
J Biol Chem; 2003 Apr; 278(15):13442-52. PubMed ID: 12551903
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.
Dichek HL; Brecht W; Fan J; Ji ZS; McCormick SP; Akeefe H; Conzo L; Sanan DA; Weisgraber KH; Young SG; Taylor JM; Mahley RW
J Biol Chem; 1998 Jan; 273(4):1896-903. PubMed ID: 9442022
[TBL] [Abstract][Full Text] [Related]
18. Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele.
Chen Z; Fitzgerald RL; Li G; Davidson NO; Schonfeld G
J Lipid Res; 2004 Jan; 45(1):155-63. PubMed ID: 13130124
[TBL] [Abstract][Full Text] [Related]
19. Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2).
Groenewegen WA; Krul ES; Averna MR; Pulai J; Schonfeld G
Arterioscler Thromb; 1994 Nov; 14(11):1695-704. PubMed ID: 7947592
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size.
Lu S; Yao Y; Cheng X; Mitchell S; Leng S; Meng S; Gallagher JW; Shelness GS; Morris GS; Mahan J; Frase S; Mansbach CM; Weinberg RB; Black DD
J Biol Chem; 2006 Feb; 281(6):3473-83. PubMed ID: 16338933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
